ucc
  • Investigación

    Demographical Influence on Canine Patients in the Evolution of Valvular Cardiopathias Using Pharmacological and Dietary Handling in Bucaramanga and its Metropolitan Area

    DOI: https://doi.org/10.16925/sp.v9i19.706
    Vol. 9 No. 19 (2013)
    Published: 2013-12-01
    Fabián Gómez
    Favio Sánchez
    Javier Albarracín
    Edgar Toledo
    Oscar Castellanos
    Cardiovascular diseases occur frequently in dogs, especially in older dogs (> 7 years). This is the case with myxomatous valvular degeneration (mvd), which is an acquired disease whose hallmark is the presence of audible murmurs on auscultation. The aim of this research was to analyze the demographic influence on outcomes of patients with drug treatment and hyponatraemic dvm diets. We worked with 60 patients weighing up to 15 kg, females and males, whole or neutered, between 6-15 years of age who had the disease in stage B and C requiring medication and dietary support. An initial sample was taken of electrolytes (Na, Cl and K), blood count, total protein, urine specific gravity and creatinine, and imaging tests (radiology, echocardiography and electrocar diography) were performed; the animals were subsequently divided into
    three study groups of 20 patients each who were pharmacologically medicated with enalapril and spironolactone (Cardial®) and each was assigned a different diet (Mixed and concentrated Diet, Hill’s H / d and Hill’s®K / d®). The results showed that patients who were given hyponatremic diets had better clinical behavior and a higher survival rate. Patients whose owners belonged to lower socioeconomic levels also lacked the economic capacity to manage their pets using these diets, which affected the health of the patients, whose mortality rate was very high (90%).
    Keywords: Array, Array, Array, Array
    PDF (Spanish)

    How to Cite

    Gómez, F., Sánchez, F., Albarracín, J., Toledo, E., & Castellanos, O. (2013). Demographical Influence on Canine Patients in the Evolution of Valvular Cardiopathias Using Pharmacological and Dietary Handling in Bucaramanga and its Metropolitan Area. Spei Domus, 9(19), 23-27. https://doi.org/10.16925/sp.v9i19.706

    License

    En calidad de autor del artículo, declaro que este, es un trabajo original, inédito, de mi creación exclusiva, que no se ha postulado a evaluación simultánea en otra publicación y que no cuenta con algún impedimento de cualquier naturaleza para la concesión de los derechos previstos en este contrato.

    En ese sentido, me comprometo a esperar un resultado de evaluación de la revista, antes de considerar su presentación a otro medio, en caso de que la respuesta de publicación no sea positiva; adicionalmente, me comprometo a responder por cualquier acción de reivindicación, plagio u otra clase de reclamación que al respecto pudiera sobrevivir por parte de terceros.

    Asimismo, declaro que como autor o coautor, estoy de acuerdo por completo con los contenidos presentados en este trabajo y cedo todos los derechos patrimoniales, es decir, la reproducción, comunicación pública, distribución, divulgación, transformación, puesta a disposición y demás formas de explotación de la obra por cualquier medio o procedimiento, a la revista y a la Editorial de la Universidad Cooperativa de Colombia.

    References

    Ware WA. Acquired valve disease. Cardiovascular disease in small animal medicine. Londres: Manson Publishing; 2007. 263-279.

    Gómez L. Degenerative valve disease in dogs: update on diagnosis, treatment and prognosis. Rev Colomb Cienc Pecu. Abr‑Jun 2011; 24(2): 201‑208.

    Whitney JC. Cardiovascular pathology. J Small Anim Pract. 1967; 8(8): 459‑465.

    Buchaman JW. Chronic valvular disease (endocardiosis) in dogs. Adv Vet Sci Comp Med. 1977; 21: 75‑106.

    Borgarelli M, Buchanan JW. Historical review, epidemiology and natural history of degenerative mitral valve disease. J Vet Cardiol. Mar 2012; 14(1): 93‑101.

    Chatterjee K. Neurohormonal activation in congestive heart failure and the role of vasopressin. Am J Cardiol. May 2005; 95(9A):8B‑13B.

    Jeunesse MS, Woehrle F, Scheneider M, Pharm D, Lefebvre HP. Effect of spironolactone on diuresis and urine sodium and potassium excretion in healthy dogs. J Vet Cardiol. Nov 2007; 9(2): 63-8.

    Dillon AR, Dell’Italia LJ, Tilson M, Killingsworth C, Denney T, Hathcock J, et al. Left ventricular remodeling in preclinical experimental mitral regurgitation of dogs. J Vet Cardiol. 2012; 14(1): 73-92.

    Mucha CJ. Degeneración valvular mixomatosa. redvet. Jul 2007; 8(7): 1‑7.

    Kogure K. Pathology of chronic mitral valvular disease in the dog. Nippon Juigaku Zasshi. 1980; 42(3): 323‑35.

    Atkins C, Keene B, Brown W, Coats J, Crawford M, De Francesco T, et al. Results of the veterinary enalapril trial to prove reduction in onset of heart failure in dogs chronically treated with enalapril alone for compensated, naturally occurring mitral valve insufficiency. J Vet Intern Med. Oct 2007; 231(7): 1061‑9.

    Atkins C, Bonagura J, Ettinger S, Fox P, Gordon S, Haggstrom J, et al. Guidelines for the diagnosis and treatment of canine chronic valvular heart disease. J Vet Inter Med. Nov‑Dec 2009; 23(6): 1142‑50.

    Bretschneider J. Pathologie und pathogenese der sogenannten

    endocarditis valvularis chronica fibrosa des hundes. Diss, Universitat Giessen, Giessne. 1962.

    Das KM, Tashjian RJ. Chronic mitral valve disease in the dog. Vet Med Small Anim Clin. 1965; 60(12): 1209‑16.

    Detweiler DK, Patterson DF. The prevalence and types of cardiovascular disease in dogs. Ann N Y Acad Sci. Sep 1965; 127(1): 481-516.

    Gaasch WH, Aurigemma GP. Inhibition of the reninangiotensin

    system and the left ventricular adaptation to mitral regurgitation. J Am Coll Cardiol. Abr 2002; 39(8): 1380‑3.

    Gaasch WH, Meyer TE. Left ventricular response to mitral

    regurgitation: implications for management. Circulation. Nov 2008; 118(22): 2298‑303.

    Pedersen HD, Häggström J. Mitral valve prolapsed in the dog: a model of mitral valve prolapse in man. Cardiovasc Res. 2000; 47(2): 234‑43.

    Buchaman JW, Bucheler J. Vertebral scale system to measure canine Heart size in radiographs. J Am Vet Med Assoc. Ene 1995; 206(9): 194‑9.

    Reyes JP, Gómez FA, Sanchéz F, Albarracín JH, Toledo EH. Myxomatous valve degeneration a look at the latest developments of disease. Spei Domus. 2013; 9(18): 49-58.

    Chetboul V, Tissier R. Echocardiographic assessment of canine degenerative mitral valve disease. J Veterinary Cardiol. Mar 2012; 14(1): 127‑48.

    Griffiths LG, Fransioli JR, Chigerwe M. Echocardiographic assessment of interventricular and intraventricular mechanical synchrony in normal dogs. J Vet Cardiol. Jun 2011; 13(2): 115‑26.

    Hezzell MJ, Boswood A, Moonarmart W, Elliott J. Selected echocardiographic variables change more rapidly in dogs that die from Myxomatous mitral valve disease. J Vet Cardiol. Mar 2012; 14(1): 269‑79.

    Atkins CE. Advances in the Management of Canine Heart Failure. Proceedings of the Congreso Latinoamericano de Emergencia y Cuidados Intensivos laveccs. 2010.

    MÉTRICAS
    ARTICLE VIEWS: 724
    PDF VIEWS: 580